Scientific Posters & Presentations

Jul 14, 2025

Glycemic Outcomes of Diazoxide Choline Extended-Release (DCCR) Tablets Administered for Hyperphagia in Individuals with Prader-Willi Syndrome Over 4 Years 664.9 KB

Jul 14, 2025

Characterization of Peripheral Edema in Individuals with Prader-Willi Syndrome During Long-term Administration of Diazoxide Choline Extended-Release Tablet (DCCR) 227 KB

Jun 30, 2025

Long-term Efficacy Results of Diazoxide Choline Extended-Release (DCCR) Tablets in Participantswith Prader-Willi Syndrome from the Completed C601 (DESTINY PWS) and C602 Open Label Extension (OLE) Studies 427.5 KB

Jun 26, 2025

United in Hope 2025 PWS Conference - Diazoxide Choline Extended-Release (DCCR) Tablets Significantly Reduce Hyperphagia in Patients with PWS who are Managed with Strict Food Controls 204.2 KB

Jun 26, 2025

United in Hope 2025 PWS Conference - Comparison of Changes in Fat Mass in Participants with PWS Treated with DCCR to Those in the NIH Natural History Study 210 KB

Jun 26, 2025

United in Hope 2025 PWS Conference - Relaxation of Food Control Parameters Based on Improvements in the Food Safe Zone Questionnaire Occurs with Reduction of Hyperphagia in Clinical Trials of DCCR in Participants with Prader-Willi Syndrome 185 KB

Jun 26, 2025

United in Hope 2025 PWS Conference - Swallowability and Dosing Compliance of Diazoxide Choline Extended-Release Tablets in Patients with Prader-Willi Syndrome 416.5 KB

May 17, 2025

PES 2025 Poster - Long-term Administration of DCCR in PWS - Changes in Changes in Lean Body Mass and Lean Mass Index 171.6 KB

May 17, 2025

PES 2025 C614 Poster - Resuming DCCR after 16-wk Randomized Withdrawal 175.6 KB

May 16, 2024

PES 2024 Poster Presentation – Long Term Safety of DCCR 64 KB

Oct 11, 2023

FPWR Research Conference 2023 798.6 KB

Jun 13, 2022

ENDO 2022 Poster Presentation 390.3 KB

May 22, 2022

Comparison of hyperphagia and problem behaviors in participants with Prader-Willi syndrome (PWS) receiving Diazoxide Choline Extended-Release (DCCR) with matched participants in PATH for PWS (PfPWS) 2.3 MB

May 05, 2021

Evaluation of Methods That Estimate Glomerular Filtration Rate in Patients With Prader-Willi Syndrome 170 KB

May 05, 2021

Abstract 2739 Therapeutic Response to DCCR (Diazoxide Choline) Extended-Release Tablets in Patients with Prader-Willi Syndrome 116.5 KB

May 05, 2021

A Phase III Study of DCCR in Prader-Willi Syndrome: Effects on Resting Energy Expenditure (REE) and Adiposity 202 KB

May 04, 2021

Application of a semi-automated framework to characterize individual experiences with DCCR in Prader-Willi syndrome 318.8 KB

Feb 04, 2021

Key Opinion Leader Meeting on DCCR for Treatment of Prader-Willi Syndrome 1.9 MB

Nov 03, 2020

A Phase III Study of DCCR in Prader-Willi Syndrome: Effects on Body Composition and Adipokines 636 KB

Jun 08, 2020

Soleno Therapeutics Phase III DESTINY PWS Trial Results 410.2 KB

Nov 15, 2018

DCCR Fat Loss Poster Presentation at Obesity Society November 2018 215.5 KB

Oct 04, 2018

DCCR Overall Safety Poster Presentation at FPWR October 2018 96 KB

Oct 04, 2018

DCCR Mode of Action Oral Presentation at FPWR October 2018 2.4 MB

Sep 29, 2018

DCCR Pharmacokinetics -Poster Presentation at ESPE 2018.pdf 205.9 KB

Sep 29, 2018

DCCR Glycemic Impact - Poster Presentation at ESPE 2018 510.7 KB

Sep 14, 2017

DCCR in PWS – Poster Presentation at the 10th International Meeting of Pediatric Endocrinology 500.5 KB

P1-1161 Efficacy and Safety of Diazoxide Choline Controlled-Release Tablet in Patients with Prader-Willi syndrome, an Updated An 670.6 KB